0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sutureless Biological Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11G17667
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sutureless Biological Valve Market Research Report 2024
BUY CHAPTERS

Global Sutureless Biological Valve Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11G17667
Report
October 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sutureless Biological Valve Market

The global Sutureless Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Public Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Sutureless Biological Valve leading manufacturers including Edwards Lifesciences, LivaNova, Medtronic, Corcym, Pulmonx, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology, etc., dominate supply; the top five capture approximately % of global revenue, with Edwards Lifesciences leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sutureless Biological Valve market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Sutureless Biological Valve Market Report

Report Metric Details
Report Name Sutureless Biological Valve Market
Segment by Type
  • Aorta
  • Pulmonary
  • Mitral Valve
  • Other
Segment by Application
  • Public Hospital
  • Private Hospital
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Edwards Lifesciences, LivaNova, Medtronic, Corcym, Pulmonx, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Sutureless Biological Valve study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Sutureless Biological Valve Market report?

Ans: The main players in the Sutureless Biological Valve Market are Edwards Lifesciences, LivaNova, Medtronic, Corcym, Pulmonx, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology

What are the Application segmentation covered in the Sutureless Biological Valve Market report?

Ans: The Applications covered in the Sutureless Biological Valve Market report are Public Hospital, Private Hospital

What are the Type segmentation covered in the Sutureless Biological Valve Market report?

Ans: The Types covered in the Sutureless Biological Valve Market report are Aorta, Pulmonary, Mitral Valve, Other

Recommended Reports

Heart Valve Devices

Surgical Sutures

Bio-Implants & Materials

1 Study Coverage
1.1 Introduction to Sutureless Biological Valve: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sutureless Biological Valve Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Aorta
1.2.3 Pulmonary
1.2.4 Mitral Valve
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Sutureless Biological Valve Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sutureless Biological Valve Revenue Estimates and Forecasts 2020-2031
2.2 Global Sutureless Biological Valve Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sutureless Biological Valve Sales Estimates and Forecasts 2020-2031
2.4 Global Sutureless Biological Valve Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sutureless Biological Valve Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sutureless Biological Valve Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Aorta Market Size by Manufacturers
3.5.2 Pulmonary Market Size by Manufacturers
3.5.3 Mitral Valve Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Sutureless Biological Valve Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sutureless Biological Valve Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Sutureless Biological Valve Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sutureless Biological Valve Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sutureless Biological Valve Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sutureless Biological Valve Sales and Revenue by Type (2020-2031)
6.4 North America Sutureless Biological Valve Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sutureless Biological Valve Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sutureless Biological Valve Sales and Revenue by Type (2020-2031)
7.4 Europe Sutureless Biological Valve Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sutureless Biological Valve Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sutureless Biological Valve Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Sutureless Biological Valve Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sutureless Biological Valve Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sutureless Biological Valve Sales and Revenue by Type (2020-2031)
9.4 Central and South America Sutureless Biological Valve Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sutureless Biological Valve Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sutureless Biological Valve Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Sutureless Biological Valve Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sutureless Biological Valve Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Sutureless Biological Valve Product Models, Descriptions and Specifications
11.1.4 Edwards Lifesciences Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Edwards Lifesciences Sutureless Biological Valve Sales by Product in 2024
11.1.6 Edwards Lifesciences Sutureless Biological Valve Sales by Application in 2024
11.1.7 Edwards Lifesciences Sutureless Biological Valve Sales by Geographic Area in 2024
11.1.8 Edwards Lifesciences Sutureless Biological Valve SWOT Analysis
11.1.9 Edwards Lifesciences Recent Developments
11.2 LivaNova
11.2.1 LivaNova Corporation Information
11.2.2 LivaNova Business Overview
11.2.3 LivaNova Sutureless Biological Valve Product Models, Descriptions and Specifications
11.2.4 LivaNova Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 LivaNova Sutureless Biological Valve Sales by Product in 2024
11.2.6 LivaNova Sutureless Biological Valve Sales by Application in 2024
11.2.7 LivaNova Sutureless Biological Valve Sales by Geographic Area in 2024
11.2.8 LivaNova Sutureless Biological Valve SWOT Analysis
11.2.9 LivaNova Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Sutureless Biological Valve Product Models, Descriptions and Specifications
11.3.4 Medtronic Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Sutureless Biological Valve Sales by Product in 2024
11.3.6 Medtronic Sutureless Biological Valve Sales by Application in 2024
11.3.7 Medtronic Sutureless Biological Valve Sales by Geographic Area in 2024
11.3.8 Medtronic Sutureless Biological Valve SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Corcym
11.4.1 Corcym Corporation Information
11.4.2 Corcym Business Overview
11.4.3 Corcym Sutureless Biological Valve Product Models, Descriptions and Specifications
11.4.4 Corcym Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Corcym Sutureless Biological Valve Sales by Product in 2024
11.4.6 Corcym Sutureless Biological Valve Sales by Application in 2024
11.4.7 Corcym Sutureless Biological Valve Sales by Geographic Area in 2024
11.4.8 Corcym Sutureless Biological Valve SWOT Analysis
11.4.9 Corcym Recent Developments
11.5 Pulmonx
11.5.1 Pulmonx Corporation Information
11.5.2 Pulmonx Business Overview
11.5.3 Pulmonx Sutureless Biological Valve Product Models, Descriptions and Specifications
11.5.4 Pulmonx Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Pulmonx Sutureless Biological Valve Sales by Product in 2024
11.5.6 Pulmonx Sutureless Biological Valve Sales by Application in 2024
11.5.7 Pulmonx Sutureless Biological Valve Sales by Geographic Area in 2024
11.5.8 Pulmonx Sutureless Biological Valve SWOT Analysis
11.5.9 Pulmonx Recent Developments
11.6 Braile Biomedica
11.6.1 Braile Biomedica Corporation Information
11.6.2 Braile Biomedica Business Overview
11.6.3 Braile Biomedica Sutureless Biological Valve Product Models, Descriptions and Specifications
11.6.4 Braile Biomedica Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Braile Biomedica Recent Developments
11.7 Colibri Heart Valve
11.7.1 Colibri Heart Valve Corporation Information
11.7.2 Colibri Heart Valve Business Overview
11.7.3 Colibri Heart Valve Sutureless Biological Valve Product Models, Descriptions and Specifications
11.7.4 Colibri Heart Valve Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Colibri Heart Valve Recent Developments
11.8 Jiecheng Medical Technology
11.8.1 Jiecheng Medical Technology Corporation Information
11.8.2 Jiecheng Medical Technology Business Overview
11.8.3 Jiecheng Medical Technology Sutureless Biological Valve Product Models, Descriptions and Specifications
11.8.4 Jiecheng Medical Technology Sutureless Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Jiecheng Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sutureless Biological Valve Industry Chain
12.2 Sutureless Biological Valve Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sutureless Biological Valve Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sutureless Biological Valve Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sutureless Biological Valve Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sutureless Biological Valve Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Sutureless Biological Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Sutureless Biological Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Sutureless Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Sutureless Biological Valve Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sutureless Biological Valve Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Sutureless Biological Valve Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Sutureless Biological Valve Sales by Region (2020-2025) & (Units)
 Table 8. Global Sutureless Biological Valve Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Sutureless Biological Valve Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Sutureless Biological Valve Sales Share by Manufacturers (2020-2025)
 Table 12. Global Sutureless Biological Valve Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Sutureless Biological Valve Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Sutureless Biological Valve by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sutureless Biological Valve as of 2024)
 Table 16. Global Sutureless Biological Valve Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Sutureless Biological Valve Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Sutureless Biological Valve Manufacturing Base and Headquarters
 Table 19. Global Sutureless Biological Valve Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Sutureless Biological Valve Sales by Type (2020-2025) & (Units)
 Table 23. Global Sutureless Biological Valve Sales by Type (2026-2031) & (Units)
 Table 24. Global Sutureless Biological Valve Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Sutureless Biological Valve Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Sutureless Biological Valve ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Sutureless Biological Valve Sales by Application (2020-2025) & (Units)
 Table 29. Global Sutureless Biological Valve Sales by Application (2026-2031) & (Units)
 Table 30. Sutureless Biological Valve High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Sutureless Biological Valve Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Sutureless Biological Valve Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Sutureless Biological Valve ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Sutureless Biological Valve Growth Accelerators and Market Barriers
 Table 37. North America Sutureless Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Sutureless Biological Valve Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Sutureless Biological Valve Growth Accelerators and Market Barriers
 Table 40. Europe Sutureless Biological Valve Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Sutureless Biological Valve Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Sutureless Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Sutureless Biological Valve Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Sutureless Biological Valve Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Sutureless Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Sutureless Biological Valve Investment Opportunities and Key Challenges
 Table 47. Central and South America Sutureless Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Sutureless Biological Valve Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Sutureless Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Edwards Lifesciences Corporation Information
 Table 51. Edwards Lifesciences Description and Major Businesses
 Table 52. Edwards Lifesciences Product Models, Descriptions and Specifications
 Table 53. Edwards Lifesciences Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Edwards Lifesciences Sales Value Proportion by Product in 2024
 Table 55. Edwards Lifesciences Sales Value Proportion by Application in 2024
 Table 56. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024
 Table 57. Edwards Lifesciences Sutureless Biological Valve SWOT Analysis
 Table 58. Edwards Lifesciences Recent Developments
 Table 59. LivaNova Corporation Information
 Table 60. LivaNova Description and Major Businesses
 Table 61. LivaNova Product Models, Descriptions and Specifications
 Table 62. LivaNova Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. LivaNova Sales Value Proportion by Product in 2024
 Table 64. LivaNova Sales Value Proportion by Application in 2024
 Table 65. LivaNova Sales Value Proportion by Geographic Area in 2024
 Table 66. LivaNova Sutureless Biological Valve SWOT Analysis
 Table 67. LivaNova Recent Developments
 Table 68. Medtronic Corporation Information
 Table 69. Medtronic Description and Major Businesses
 Table 70. Medtronic Product Models, Descriptions and Specifications
 Table 71. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Medtronic Sales Value Proportion by Product in 2024
 Table 73. Medtronic Sales Value Proportion by Application in 2024
 Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 75. Medtronic Sutureless Biological Valve SWOT Analysis
 Table 76. Medtronic Recent Developments
 Table 77. Corcym Corporation Information
 Table 78. Corcym Description and Major Businesses
 Table 79. Corcym Product Models, Descriptions and Specifications
 Table 80. Corcym Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Corcym Sales Value Proportion by Product in 2024
 Table 82. Corcym Sales Value Proportion by Application in 2024
 Table 83. Corcym Sales Value Proportion by Geographic Area in 2024
 Table 84. Corcym Sutureless Biological Valve SWOT Analysis
 Table 85. Corcym Recent Developments
 Table 86. Pulmonx Corporation Information
 Table 87. Pulmonx Description and Major Businesses
 Table 88. Pulmonx Product Models, Descriptions and Specifications
 Table 89. Pulmonx Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Pulmonx Sales Value Proportion by Product in 2024
 Table 91. Pulmonx Sales Value Proportion by Application in 2024
 Table 92. Pulmonx Sales Value Proportion by Geographic Area in 2024
 Table 93. Pulmonx Sutureless Biological Valve SWOT Analysis
 Table 94. Pulmonx Recent Developments
 Table 95. Braile Biomedica Corporation Information
 Table 96. Braile Biomedica Description and Major Businesses
 Table 97. Braile Biomedica Product Models, Descriptions and Specifications
 Table 98. Braile Biomedica Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Braile Biomedica Recent Developments
 Table 100. Colibri Heart Valve Corporation Information
 Table 101. Colibri Heart Valve Description and Major Businesses
 Table 102. Colibri Heart Valve Product Models, Descriptions and Specifications
 Table 103. Colibri Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Colibri Heart Valve Recent Developments
 Table 105. Jiecheng Medical Technology Corporation Information
 Table 106. Jiecheng Medical Technology Description and Major Businesses
 Table 107. Jiecheng Medical Technology Product Models, Descriptions and Specifications
 Table 108. Jiecheng Medical Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Jiecheng Medical Technology Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sutureless Biological Valve Product Picture
 Figure 2. Global Sutureless Biological Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Aorta Product Picture
 Figure 4. Pulmonary Product Picture
 Figure 5. Mitral Valve Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Sutureless Biological Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Public Hospital
 Figure 9. Private Hospital
 Figure 10. Sutureless Biological Valve Report Years Considered
 Figure 11. Global Sutureless Biological Valve Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Sutureless Biological Valve Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Sutureless Biological Valve Revenue Market Share by Region (2020-2031)
 Figure 15. Global Sutureless Biological Valve Sales (2020-2031) & (Units)
 Figure 16. Global Sutureless Biological Valve Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Sutureless Biological Valve Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Sutureless Biological Valve Sales Volume Market Share in 2024
 Figure 19. Global Sutureless Biological Valve Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Aorta Revenue Market Share by Manufacturer in 2024
 Figure 22. Pulmonary Revenue Market Share by Manufacturer in 2024
 Figure 23. Mitral Valve Revenue Market Share by Manufacturer in 2024
 Figure 24. Other Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Sutureless Biological Valve Sales Market Share by Type (2020-2031)
 Figure 26. Global Sutureless Biological Valve Revenue Market Share by Type (2020-2031)
 Figure 27. Global Sutureless Biological Valve Sales Market Share by Application (2020-2031)
 Figure 28. Global Sutureless Biological Valve Revenue Market Share by Application (2020-2031)
 Figure 29. North America Sutureless Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 30. North America Sutureless Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Sutureless Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 32. North America Sutureless Biological Valve Sales Volume (Units) by Type (2020- 2031)
 Figure 33. North America Sutureless Biological Valve Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Sutureless Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 35. North America Sutureless Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Sutureless Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 40. Europe Sutureless Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Sutureless Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Sutureless Biological Valve Sales Volume (Units) by Type (2020-2031)
 Figure 43. Europe Sutureless Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Sutureless Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 45. Europe Sutureless Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 47. France Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Sutureless Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 52. Asia-Pacific Sutureless Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Sutureless Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Sutureless Biological Valve Sales Volume (Units) by Type (2020- 2031)
 Figure 55. Asia-Pacific Sutureless Biological Valve Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Sutureless Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 57. Asia-Pacific Sutureless Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 62. India Sutureless Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Sutureless Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 64. Central and South America Sutureless Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Sutureless Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Sutureless Biological Valve Sales Volume (Units) by Type (2021-2031)
 Figure 67. Central and South America Sutureless Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Sutureless Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 69. Central and South America Sutureless Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Sutureless Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Sutureless Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Sutureless Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 73. Middle East and Africa Sutureless Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Sutureless Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Sutureless Biological Valve Sales Volume (Units) by Type (2021-2031)
 Figure 76. South America Sutureless Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Sutureless Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 78. Middle East and Africa Sutureless Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Sutureless Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Sutureless Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Sutureless Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Sutureless Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 83. Sutureless Biological Valve Industry Chain Mapping
 Figure 84. Regional Sutureless Biological Valve Manufacturing Base Distribution (%)
 Figure 85. Global Sutureless Biological Valve Production Market Share by Region (2020-2031)
 Figure 86. Sutureless Biological Valve Production Process
 Figure 87. Regional Sutureless Biological Valve Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona